A Double-Labeling Assay for Simultaneous Estimation and Characterization of Estrogen and Progesterone Receptors using Radioiodinated Estradiol and Tritiated Org 2058
- 1 June 1986
- journal article
- research article
- Published by SAGE Publications in Tumori Journal
- Vol. 72 (3) , 251-257
- https://doi.org/10.1177/030089168607200305
Abstract
Estrogen (ER) and progesterone receptors (PgR) appear to be a prerequisite to elicit a biologic response by a hormone-target organ. Current methodologies for analysis of these proteins (e.g., dextran-coated charcoal, DCC) in single-label assay (SLA) require relatively large amounts of tissue material, time and laboriousness. Therefore, we have developed for breast cancer tissue an improved dual-label assay (DLA) for simultaneous titration (by DCC) and/or characterization (by sedimentation properties) of ER and PgR on the same sample, using 125I-E2 and 3H-Org 2058 as tracers. The interaction of 125I-E2 with ER and plasma proteins in comparison to 3H-E2 was studied in terms of specificity, time course, affinity binding and sedimentation pattern. 125I-E2 bound the same molecular forms displayed by 3H-E2 (9 and 3S) but with lower titers (about 1.3-fold), irrespective of the technique used, and did not bind to sex hormone-binding globulin. Simultaneous detection of 125I and 3H was achieved by use of a gamma counter plus a beta counter sequentially. ER and PgR titrations with DCC in DLA were in good agreement with those obtained with SLA, in terms of titers and Ka values. An analogous result was obtained with sucrose density gradient (SDG) analysis. Both the DLA methods were highly reproducible (CV < 8.0 %). Between the rotors available for SDG, the vertical one was preferable because of the larger number of samples processed and of less purturbation of sedimenting receptor molecules. Furthermore, a biochemical application of the method is described. In conclusion, the DLA procedure, by simplifying ER and PgR estimation, makes it possible to study, even on small tumor biopsies, the molecular properties of these proteins in relation to the clinical response of the disease.This publication has 19 references indexed in Scilit:
- Criteria for the Establishment of a Double-Labeling Assay for Simultaneous Determination of Estrogen and Progesterone ReceptorsOncology, 1984
- High-performance size exclusion chromatography as a rapid method for the separation of steroid hormone receptorsJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- Assay of estradiol receptors in human breast carcinomas using the gamma emitting ligand 16α[125I]iodoestradiolThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- 14C-labeled proteins as markers for gradient analysis of steroid-hormone receptors.Clinical Chemistry, 1981
- Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. workshop, held on 16–17 March, 1979, in the Netherlands Cancer InstitutePublished by Elsevier ,1980
- Interaction of 16 alpha-[125I]iodo-estradiol with estrogen receptor and other steroid-binding proteins.Proceedings of the National Academy of Sciences, 1980
- The binding of progesterone, R-5020 and ORG-2058 to progesterone receptorPublished by Elsevier ,1979
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- A graphic method for the determination and presentation of binding parameters in a complex systemAnalytical Biochemistry, 1967
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949